The pharmaceutical landscape for blood sugar is changing, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this approach offers a more convenient way to provide https://zubairbqia651663.gynoblog.com/39758920/glp-1-patches-a-innovative-approach-to-blood-sugar-control